Generation of anti-FN14 monoclonal antibodies by ex-vivo accelerated antibody evolution

摘要

The present invention relates generally to anti-FN14 antibodies. In particular, the anti-FN14 antibodies described herein are useful for the treatment of diseases, such as a variety of cancers, associated with expression of FN14.